Tatiana F. Vieira

Mrs. Tatiana F. Vieira

UCIBIO – Applied Molecular Biosciences Unit, BioSIM - Departamento de Biomedicina, Faculdade de Medicina, Universidade do Porto, 4200-319 Porto, Portugal
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2019 in Applied Sciences
Verified
Journal Article
Open access
PDF file
Tatiana F. VieiraTatiana F. Vieira
Tatiana F. Vieira
Sergio F. SousaSergio F. Sousa
Sergio F. Sousa
AutoDock and Vina are two of the most widely used protein–ligand docking programs. The fact that these programs are free and available under an open source license, also makes them a very popular first choice for many users and a common starting point for many virtual screening campaigns, particularly in academia. Here, we evaluated the performance of AutoDock and Vina against an unbiased dataset containing 102 protein targets, 22,432 active compounds and 1,380,513 decoy molecules. In general, the results showed that the overall performance of Vina and AutoDock was comparable in discriminating between actives and decoys. However, the results varied significantly with the type of target. AutoDock was better in discriminating ligands and decoys in more hydrophobic, poorly polar and poorly charged pockets, while Vina tended to give better results for polar and charged binding pockets. For the type of ligand, the tendency was the same for both Vina and AutoDock. Bigger and more flexible ligands still presented a bigger challenge for these docking programs. A set of guidelines was formulated, based on the strengths and weaknesses of both docking program and their limits of validation.

18 October 2021 in RSC Advances
Verified
Journal Article
Open access
PDF file
CNCarolina M. Natal
Carolina M. Natal
MFMaria José G. Fernandes
Maria José G. Fernandes
NPNuno F. S. Pinto
Nuno F. S. Pinto
Renato PereiraRenato Pereira
Renato Pereira
Tatiana F. VieiraTatiana F. Vieira
Tatiana F. Vieira
M. Sameiro GonçalvesM. Sameiro Gonçalves
M. Sameiro Gonçalves
Thymol and carvacrol derivatives were synthesised. Two of them proved to be mildly active againstSf9insect cell line and one has presented selectivity by proving to be less toxic to human cells than the naturally derived starting materials.

31 January 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
Tatiana F. VieiraTatiana F. Vieira
Tatiana F. Vieira
RMRita Magalhães
Rita Magalhães
Manuel SimõesManuel Simões
Manuel Simões
Sergio F. SousaSergio F. Sousa
Sergio F. Sousa
Pseudomonas aeruginosa is an opportunistic Gram-negative bacterium responsible for acute and chronic infections in planktonic state or in biofilms. The sessile structures are known to confer physical stability, increase virulence, and work as a protective armor against antimicrobial compounds. P. aeruginosa can control the expression of genes, population density, and biofilm formation through a process called quorum sensing (QS), a rather complex and hierarchical system of communication. A recent strategy to try and overcome bacterial resistance is to target QS proteins. In this study, a combined multi-level computational approach was applied to find possible inhibitors against P. aeruginosa QS regulator protein MvfR, also known as PqsR, using a database of approved FDA drugs, as a repurposing strategy. Fifteen compounds were identified as highly promising putative MvfR inhibitors. On those 15 MvfR ligand complexes, molecular dynamic simulations and MM/GBSA free-energy calculations were performed to confirm the docking predictions and elucidate on the mode of interaction. Ultimately, the five compounds that presented better binding free energies of association than the reference molecules (a known antagonist, M64 and a natural inducer, 2-nonyl-4-hydroxyquinoline) were highlighted as very promising MvfR inhibitors.

7 August 2018 in ChemistrySelect
Verified
Journal Article
Closed access
PDF file
Sergio F. SousaSergio F. Sousa
Sergio F. Sousa
JPJoana Peres
Joana Peres
MCManuel A.N. Coelho
Manuel A.N. Coelho
Tatiana F. VieiraTatiana F. Vieira
Tatiana F. Vieira

27 April 2024 in Microbial Pathogenesis
Verified
Journal Article
Open access
MLMiguel M. Leitão
Miguel M. Leitão
Tatiana F. VieiraTatiana F. Vieira
Tatiana F. Vieira
SSSérgio F. Sousa
Sérgio F. Sousa
Fernanda BorgesFernanda Borges
Fernanda Borges
Manuel SimõesManuel Simões
Manuel Simões
Anabela BorgesAnabela Borges
Anabela Borges

1 September 2020 in Trends in Biotechnology
Verified
Journal Article
Closed access
RMRita Magalhães
Rita Magalhães
Tatiana F. VieiraTatiana F. Vieira
Tatiana F. Vieira
Henrique FernandesHenrique Fernandes
Henrique Fernandes
AMAndré Alberto Melo
André Alberto Melo
Manuel SimõesManuel Simões
Manuel Simões
Sergio F. SousaSergio F. Sousa
Sergio F. Sousa